Stark disparities based on sex and race in the use of life-saving implantable cardioverter defibrillator (ICD) interventions suggest potential bias in care pathways implemented by electrophysiologists, according to results of a clinical trial presented by researchers at the Jacobs School of Medicine and Biomedical Sciences.
Twenty-seven doctoral, 58 master’s and 192 baccalaureate candidates were eligible to receive degrees in biomedical science fields during the May 17 virtual commencement ceremony.
The novel coronavirus has caused massive upheaval in everyone’s lives. Aside from patients and their families, those whose lives have been most altered are those on the front lines ─ the health care workers whose jobs require them to face the virus firsthand each day.
The inaugural Medical Education and Educational Research Institute (MEERI) Conference continued the ongoing effort on evidence-based teaching and learning as the Jacobs School of Medicine and Biomedical Sciences plans for a redesigned curriculum format.
The Jacobs School of Medicine and Biomedical Sciences is participating in a national effort being coordinated by the Mayo Clinic to collect convalescent plasma as a possible therapy for COVID-19 patients.
With COVID-19 tests and testing materials in short supply across the nation, researchers at the Jacobs School of Medicine and Biomedical Sciences have joined together to help compensate for the shortage.
A three-year national study will explore whether earlier diagnosis of atrial fibrillation, combined with appropriate treatment, can improve health outcomes — including reducing the risk of stroke.
Researchers in the Department of Medicine used a quality improvement project to dramatically reduce inappropriate proton pump inhibitor (PPI) prescriptions at a safety net clinic.
Postponing spring holiday family gatherings this year due to the COVID-19 global health pandemic may be the best option, suggests Thomas A. Russo, MD, professor of medicine and chief of infectious diseases.
